Home
/ Ionetix
/ Competitors

Ionetix Competitors and Similar CompaniesClear all

Ionetix's competitors and similar companies include Bioclinic Group, Certest Biotec, Trinity Biotech and Exact Sciences.

	Ionetix Ionetix is a company developing solutions for cardiac positron-emission tomography.	Bioclinic Group Bioclinic is a company that operates a network of medical biology laboratories.	Certest Biotec Certest Biotec is a biotechnology company dedicated to the development and manufacture of in vitro diagnostic products with human applications.	Trinity Biotech Trinity Biotech is a company that specializes in the development, manufacture, and marketing of diagnostic test kits.	Exact Sciences Exact Sciences is a company that provides cancer screening and diagnostic test products.
Founding Date	Founding Date 2010	Founding Date 1995	Founding Date 2002	Founding Date 1992	Founding Date 1995
Type	Type Private	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech medical diagnostics medtech	Tags Healthcare biotech medical diagnostics medtech	Tags Healthcare biotech medical diagnostics medtech	Tags Healthcare biotech medical diagnostics medtech	Tags Healthcare biotech medical diagnostics medtech
Locations	Locations Lansing, US HQ San Francisco, US	Locations Paris, FR HQ	Locations San Mateo de Gállego, ES HQ	Locations Bray, IE HQ Jamestown, US	Locations Madison, US HQ Paris, FR Cologne, DE Milan, IT Tokyo, JP Baar, CH London, GB see more
Employees	Employees 652% increase	Employees 2223% increase	Employees 2202% increase	Employees 380	Employees 6,5003% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 19.1 m	Valuation ($) 12.8 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $61.6m (FY, 2024)	Revenue (est.) $3.2b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods $38.2m (FY, 2024)	Cost of goods $984.2m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit $23.3m (FY, 2024)	Gross profit $2.3b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ($31.2m) (FY, 2024)	Net income ($207.9m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 38.3m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 874.3m